EyemTech

EyemTech is a China-based biotechnology company specializing in organ-on-a-chip (OOC) technology and microfluidic systems for precision medicine and drug development. The company develops high-fidelity in vitro models that mimic human organ functions to improve the accuracy of drug toxicity testing and efficacy screening. EyemTech's platform is particularly focused on oncology, providing personalized drug sensitivity testing for cancer patients using patient-derived tumor-on-a-chip models. By bridging the gap between traditional cell cultures and animal models, the company aims to accelerate drug discovery and enable more effective clinical decision-making. Their technology integrates microfluidics, tissue engineering, and artificial intelligence to provide comprehensive solutions for both clinical diagnostics and pharmaceutical R&D. The company has established collaborations with major pharmaceutical firms and clinical institutions to validate its platform in real-world settings.